Literature DB >> 30559213

Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora.

Christine Tedijanto1, Scott W Olesen2, Yonatan H Grad2,3, Marc Lipsitch4,2.   

Abstract

Bystander selection-the selective pressure for resistance exerted by antibiotics on microbes that are not the target pathogen of treatment-is critical to understanding the total impact of broad-spectrum antibiotic use on pathogenic bacterial species that are often carried asymptomatically. However, to our knowledge, this effect has never been quantified. We quantify bystander selection for resistance for a range of clinically relevant antibiotic-species pairs as the proportion of all antibiotic exposures received by a species for conditions in which that species was not the causative pathogen ("proportion of bystander exposures"). Data sources include the 2010-2011 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, the Human Microbiome Project, and additional carriage and etiological data from existing literature. For outpatient prescribing in the United States, we find that this proportion over all included antibiotic classes is over 80% for eight of nine organisms of interest. Low proportions of bystander exposure are often associated with infrequent bacterial carriage or concentrated prescribing of a particular antibiotic for conditions caused by the species of interest. Applying our results, we roughly estimate that pneumococcal conjugate vaccination programs result in nearly the same proportional reduction in total antibiotic exposures of Streptococcus pneumoniae, Staphylococcus aureus, and Escherichia coli, despite the latter two organisms not being targeted by the vaccine. These results underscore the importance of considering antibiotic exposures of bystanders, in addition to the target pathogen, in measuring the impact of antibiotic resistance interventions.

Entities:  

Keywords:  antibiotic resistance; microbiome; vaccines

Mesh:

Substances:

Year:  2018        PMID: 30559213      PMCID: PMC6304942          DOI: 10.1073/pnas.1810840115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Deciphering the Impact of Bystander Selection for Antibiotic Resistance in Neisseria gonorrhoeae.

Authors:  Scott W Olesen; Yonatan H Grad
Journal:  J Infect Dis       Date:  2020-03-16       Impact factor: 5.226

2.  Impact of Species Diversity on the Design of RNA-Based Diagnostics for Antibiotic Resistance in Neisseria gonorrhoeae.

Authors:  Crista B Wadsworth; Mohamad R A Sater; Roby P Bhattacharyya; Yonatan H Grad
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

3.  Antimicrobial resistance and the role of vaccines.

Authors:  David E Bloom; Steven Black; David Salisbury; Rino Rappuoli
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-18       Impact factor: 11.205

4.  Back into the wild: how resistant pathogens become susceptible again?

Authors:  Solen Kernéis; Sandrine Valade; Paul-Louis Woerther
Journal:  Intensive Care Med       Date:  2020-02-03       Impact factor: 17.440

5.  A game theoretic approach reveals that discretizing clinical information can reduce antibiotic misuse.

Authors:  Maya Diamant; Shoham Baruch; Eias Kassem; Khitam Muhsen; Dov Samet; Moshe Leshno; Uri Obolski
Journal:  Nat Commun       Date:  2021-02-19       Impact factor: 14.919

6.  Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control.

Authors:  Laura Temime; Lulla Opatowski; David Rm Smith
Journal:  Elife       Date:  2021-09-14       Impact factor: 8.140

7.  The Population Genomics of Increased Virulence and Antibiotic Resistance in Human Commensal Escherichia coli over 30 Years in France.

Authors:  Erick Denamur; François Blanquart; Julie Marin; Olivier Clermont; Guilhem Royer; Mélanie Mercier-Darty; Jean Winoc Decousser; Olivier Tenaillon
Journal:  Appl Environ Microbiol       Date:  2022-07-18       Impact factor: 5.005

8.  Impact of antibiotics on off-target infant gut microbiota and resistance genes in cohort studies.

Authors:  Rebecca M Lebeaux; Juliette C Madan; Quang P Nguyen; Modupe O Coker; Erika F Dade; Yuka Moroishi; Thomas J Palys; Benjamin D Ross; Melinda M Pettigrew; Hilary G Morrison; Margaret R Karagas; Anne G Hoen
Journal:  Pediatr Res       Date:  2022-05-14       Impact factor: 3.953

Review 9.  Uses of mathematical modeling to estimate the impact of mass drug administration of antibiotics on antimicrobial resistance within and between communities.

Authors:  Scott W Olesen
Journal:  Infect Dis Poverty       Date:  2022-06-30       Impact factor: 10.485

10.  Choosing New Therapies for Gonorrhoea: We Need to Consider the Impact on the Pan-Neisseria Genome. A Viewpoint.

Authors:  Chris Kenyon; Jolein Laumen; Sheeba Manoharan-Basil
Journal:  Antibiotics (Basel)       Date:  2021-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.